MENU
DAWN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Day One Biopharmaceuticals (DAWN) Ownership - Who owns Day One Biopharmaceuticals?
Profile
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.37B
P/E Ratio
N/A
Total Cash
361.87M
Projected Growth
N/A
Total Debt
190K
Revenue
8.19M
Risk (Beta)
-1.56
Dividend Yield
N/A
Total Cash/Share
3.68
Total Debt/Equity
N/A
Revenue/Share
0.09 USD as % of share price
Fundamentals
DAWN
Capitalization
1.37B
P/E Ratio
N/A
Risk (Beta)
-1.56
Dividend Yield
N/A
Total Cash
362M
Total Cash/Share
3.68
Total Debt
190K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.09%
Revenue
8.19M
ROE
N/A
Book Value
307M
P/B Ratio
4.45
Cash Flow
N/A
Earnings
-1.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
4.09
Current Revenue Per Employee
47080.46
Dividends Per Share - Security
N/A
EBITDA
-291.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.37
Revenue To Assets
-39.35
Shares Held By Institutions
1.56B
Shares Outstanding - Current
98.3M
Total Liabilities
93.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
2.808
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com